Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network.
about
Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary diseasePneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis.Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumoniaClinical and temporal patterns of severe pneumonia causing critical illness during HajjInternational pneumococcal clones match or exceed the fitness of other strains despite the accumulation of antibiotic resistance.Clinical outcomes and microbiological characteristics of severe pneumonia in cancer patients: a prospective cohort study.Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired PneumoniaIncidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH.PROGRESS - prospective observational study on hospitalized community acquired pneumoniaAdvances in the prevention, management, and treatment of community-acquired pneumoniaMicrobiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines.Elderly patients with community-acquired pneumonia: optimal treatment strategies.Current treatment of community-acquired pneumonia.[CAPNETZ. The competence network for community-acquired pneumonia (CAP)].Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation.Pneumolysin-mediated expression of β-defensin 2 is coordinated by p38 MAP kinase-MKP1 in human airway cells.Induction of human β-defensin-2 in pulmonary epithelial cells by Legionella pneumophila: involvement of TLR2 and TLR5, p38 MAPK, JNK, NF-κB, and AP-1.Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP).The impact of global budgeting on health service utilization, health care expenditures, and quality of care among patients with pneumonia in Taiwan.The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia.Increased Severity and Mortality of CAP in COPD: Results from the German Competence Network, CAPNETZ.Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia.Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?Streptococcus pneumoniae induces human β-defensin-2 and -3 in human lung epithelium.Prevalence and determinants of hyperglycaemia in pneumonia patients.Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.Aetiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway.Anti-protein immunoglobulin M responses to pneumococcus are not associated with aging.Impact of microbial Aetiology on mortality in severe community-acquired pneumoniaViral infection in community acquired pneumonia patients with fever: a prospective observational studyA public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in GermanyCost–effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany
P2860
Q24236699-1CEBB5A5-9224-4EEC-9DE7-1B5A6E1B42BCQ30238816-402D5B4F-29A7-402B-996B-80A077004F6AQ33768450-33C9475C-F102-481E-8FC8-43AB270FF379Q33827245-F70ED27E-D90B-4D61-A3E3-F8D27DA8AC20Q34271424-4F77507A-8121-44FE-BBDE-99549479EB1AQ35270677-B61E190C-6066-4742-AC3D-00CE2EFC7BADQ35585423-BA0AD753-F700-4CC1-9190-1032F887BCADQ35883963-5254B574-EBA2-4E06-BDAF-D0D88A328288Q36184650-0DCFDC95-7ADE-4654-8581-0D4BB38D3176Q36281234-6C56083C-36D5-4C7F-A4FD-34B94CC4296AQ36816005-80FB77F8-04A7-418E-854C-515E1179CD17Q37182263-A302D379-276D-480A-AA08-0BA3F0B34D0BQ37822666-C415C683-EC9D-4C3F-AA5D-0EC54CF12BD3Q37846731-FDCAAFA0-493A-4929-B7FE-EA3E7EC7C5E9Q37896600-C48D713C-D666-43D2-80A0-8C00D15FA3A2Q38105639-267FC960-28F8-4ADC-9477-6B376989AFCAQ38382078-AF95430D-9A33-4847-AFF4-0B18C20C28D4Q38678778-04D959AF-6DAE-4E6E-88D6-E70BFDF1B4E9Q39159136-06249D20-C717-4AEE-B5D3-2DEFDA65231BQ39739676-56DA6FC5-4045-401D-BA9C-D86CBB9967F6Q40066437-189D3015-A039-43FC-B9A6-B16D35E5576AQ40248440-209EB43D-6C92-448A-B97A-E8A30BAF45E0Q41164094-2D8A1218-C055-4251-858A-C25B460E8263Q41389337-8C11FC60-E88B-4F39-BB90-6AC4F6443D64Q42251016-59D59432-0277-44FF-844E-97AE79831E50Q43079618-3EEF4264-2D46-4077-A213-48D38AD0BA98Q43561920-EA467706-A399-4C9D-AC87-673635D9E5E6Q44169122-3B11163A-3913-4892-B244-B7F969B01F70Q51595534-875A6C60-BBBF-4F4B-BE30-E5E8F4FBB212Q53516441-BDF3A104-52CC-4F5D-9C9F-246BB9545E45Q54139422-CECB2525-B4C3-40A8-A4BD-DBC1313F35F5Q55491630-0D027F74-73A8-433A-90C5-A0D89F7AE393Q57024097-E3FB7691-9908-46D5-BDF7-410B8A7FBBC6Q57025476-971935E5-0580-4F0B-AD1E-A93E4F2FFB7EQ58286118-1FF90FA1-EFE7-4BBA-A34D-FCD25D04245AQ58286129-04E5C545-4CB4-46E0-8B42-BFD81771438F
P2860
Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Global and local epidemiology ...... rience of the CAPNETZ Network.
@en
Global and local epidemiology ...... rience of the CAPNETZ Network.
@nl
type
label
Global and local epidemiology ...... rience of the CAPNETZ Network.
@en
Global and local epidemiology ...... rience of the CAPNETZ Network.
@nl
prefLabel
Global and local epidemiology ...... rience of the CAPNETZ Network.
@en
Global and local epidemiology ...... rience of the CAPNETZ Network.
@nl
P356
P1476
Global and local epidemiology ...... rience of the CAPNETZ Network.
@en
P2093
Thomas Köhnlein
P304
P356
10.1055/S-0029-1202941
P50
P577
2009-03-18T00:00:00Z